O'Connor Daniel

Director at Ayala Pharmaceuticals, Inc. · on record since Oct 29, 2013
Chief Executive Officer at Ayala Pharmaceuticals, Inc. · on record since Oct 29, 2013
SVP, Interim Gen. Counsel, Sec at IMCLONE SYSTEMS INC · on record since Feb 21, 2007
Director at DiaMedica Therapeutics Inc. · on record since Jun 3, 2026
Director at ONCOSEC MEDICAL Inc · on record since Sep 11, 2017
Director at SEELOS THERAPEUTICS, INC. · on record since Jan 28, 2019
CEO and President at ONCOSEC MEDICAL Inc · on record since Feb 1, 2019
Director at ZyVersa Therapeutics, Inc. · on record since Dec 20, 2021
Chief Executive Officer at ZyVersa Therapeutics, Inc. · on record since Dec 20, 2021
10% owner at ZyVersa Therapeutics, Inc. · on record since Dec 14, 2022
Director at Ambrx Biopharma Cayman, Inc. · on record since Jan 3, 2023
President and CEO at Ambrx Biopharma Cayman, Inc. · on record since Jan 3, 2023

Insider trading activity of O'Connor Daniel

Transactions on record: 158; since Feb 20, 2007

Open-market buys: 5; $136.9K

Open-market sells: 13; $997.6K

Companies traded: 8; last filing Jun 3, 2026

Figures computed from official regulatory filings — .

Companies where O'Connor Daniel has traded

DiaMedica Therapeutics Inc.2 tx · Jun 3, 2026
Ambrx Biopharma, Inc.7 tx · $491.1K · Mar 7, 2024
SEELOS THERAPEUTICS, INC.8 tx · $9.8K · Jan 8, 2024
Ambrx Biopharma Cayman, Inc.2 tx · Jul 7, 2023
7 tx · Dec 14, 2022
20 tx · $597.7K · May 4, 2021
106 tx · $1.4M · Jul 3, 2017
6 tx · Feb 21, 2007

Track record of O'Connor Daniel

Statistical track record

Free account

Open-market buys: 6

Last buy: Jun 1, 2022

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of O'Connor Daniel

Co-insiders of O'Connor Daniel

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
DiaMedica Therapeutics Inc.Listing on record	Jun 3, 2026	AwardD (derivative)	40,412	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DiaMedica Therapeutics Inc.Listing on record	Feb 24, 2025	AwardD (derivative)	64,242	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-772,857	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-750,000	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	Other	-48,202	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-173,785	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-294,643	—	n/a (No price was disclosed in the filing)		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jan 8, 2024	AwardD (derivative)	1,666	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma, Inc.Listing unverified	Dec 11, 2023	Award	750,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma, Inc.Listing unverified	Oct 31, 2023	Sell	-50,012	9.82 USD	$491.1K	Unusual size	SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Jul 7, 2023	AwardD (derivative)	1,216,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Apr 28, 2023	Award	2,750,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jan 5, 2023	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	OtherD (derivative)	1,750	—	n/a (No price was disclosed in the filing)		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	OtherD (derivative)	177,204	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	Other	1,377,598	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	OtherD (derivative)	1,750	—	n/a (No price was disclosed in the filing)		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jun 2, 2022	Buy	16,000	0.61 USD	$9.8K	conv 53ClusterFirst in 12mo	SEC
ZyVersa Therapeutics, Inc.Listing on record	Mar 10, 2022	OtherD (derivative)	609	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Mar 10, 2022	OtherD (derivative)	-23,404	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Mar 10, 2022	Other	42,005	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jan 6, 2022	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ONCOSEC MEDICAL IncListing on record	May 4, 2021	Sell	-3,172	4.86 USD	$15.4K		SEC
ONCOSEC MEDICAL IncListing on record	Feb 2, 2021	Sell	-3,413	7.71 USD	$26.3K		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jan 8, 2021	AwardD (derivative)	16,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
DiaMedica Therapeutics Inc.Listing on record	Jun 3, 2026	AwardD (derivative)	40,412	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DiaMedica Therapeutics Inc.Listing on record	Feb 24, 2025	AwardD (derivative)	64,242	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-772,857	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-750,000	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	Other	-48,202	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-173,785	—	n/a (No price was disclosed in the filing)		SEC
Ambrx Biopharma, Inc.Listing unverified	Mar 7, 2024	OtherD (derivative)	-294,643	—	n/a (No price was disclosed in the filing)		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jan 8, 2024	AwardD (derivative)	1,666	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma, Inc.Listing unverified	Dec 11, 2023	Award	750,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma, Inc.Listing unverified	Oct 31, 2023	Sell	-50,012	9.82 USD	$491.1K	Unusual size	SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Jul 7, 2023	AwardD (derivative)	1,216,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Ambrx Biopharma Cayman, Inc.Listing unverified	Apr 28, 2023	Award	2,750,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jan 5, 2023	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	OtherD (derivative)	1,750	—	n/a (No price was disclosed in the filing)		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	OtherD (derivative)	177,204	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	Other	1,377,598	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Dec 14, 2022	OtherD (derivative)	1,750	—	n/a (No price was disclosed in the filing)		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jun 2, 2022	Buy	16,000	0.61 USD	$9.8K	conv 53ClusterFirst in 12mo	SEC
ZyVersa Therapeutics, Inc.Listing on record	Mar 10, 2022	OtherD (derivative)	609	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Mar 10, 2022	OtherD (derivative)	-23,404	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ZyVersa Therapeutics, Inc.Listing on record	Mar 10, 2022	Other	42,005	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jan 6, 2022	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ONCOSEC MEDICAL IncListing on record	May 4, 2021	Sell	-3,172	4.86 USD	$15.4K		SEC
ONCOSEC MEDICAL IncListing on record	Feb 2, 2021	Sell	-3,413	7.71 USD	$26.3K		SEC
SEELOS THERAPEUTICS, INC.Listing on record	Jan 8, 2021	AwardD (derivative)	16,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC